5 2020 CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements
The €42.3 million change in translation adjustments mainly resulted from changes in the value of the euro against the following currencies:
26 5244276: 7/ .<97:
8.1.2. The net carrying amounts of goodwill by CGU are as follows:
Breakdown of goodwill by cash-generating unit (CGU)
26 5244276: 7/ .<97:
558.7 571.3 330.9 366.1
498.7 598.0 334.0 367.0
United Kingdom Other Europe (1)
Sopra Banking Software
Sopra HR Software
“Other Europe” comprises the following CGUs, which are tested separately: Germany, Scandinavia, Spain, Italy, Switzerland, Benelux and Sopra Financial Technology. (1)
For each business combination, the Group may elect to recognise under its balance sheet assets either partial goodwill (corresponding only to its percentage of ownership interest) or full goodwill (also including the goodwill corresponding to minority interests) according to the method for business combinations presented in Note 2.1. This decision is made on an acquisition-by-acquisition basis.
Should the calculation of goodwill result in a negative difference (bargain purchase), the Group recognises the resulting gain entirely in profit or loss, after reassessing whether all assets and liabilities have been correctly identified. Goodwill is allocated to cash-generating units for the purposes of impairment tests as set out in Note 8.1.3. Such tests are performed when there is an indication of impairment, and in any event at the balance sheet date of 31 December.
Impairment testing 8.1.3. The Group conducted impairment testing at 30 June because it practice. It began by reviewing its discount rate and perpetual deemed the consequences of the Covid-19 crisis constituted an growth rate parameters with respect to 31 December 2019 of the indication of impairment. The Group did not recognise any previous year. As part of the exercise, it decided not to include an impairment as a result of this testing. The Group also performed additional risk premium related to Covid-19 in calculations of its impairment tests at 31 December 2020 in line with standard discount rate.
The tests were thus performed using the following parameters: